We describe an in vitro system that emulates the specific and efficient transcriptional termination associated with the human gastrin gene terminator in vivo. The system involves a dC-tailed DNA template containing the gastrin gene terminator sequence, purified RNA polymerase II, and purified elongation factor TFIIS. In this system, the basal level of termination by RNA polymerase II at the gastrin gene terminator is specifically enhanced by netropsin, an (A+T)-rich minor groove-binding peptide. This enhanced termination is maintained even with TFUS, which normally suppresses termination at this site. In vitro termination is terminator sequence-specific. Mutant sequences that reduce or abolish termination in vivo show corresponding reductions in activity in the in vitro system. This in vitro emulation of in vivo activities of wild-type and mutant terminators strongly suggests that netropsin and a putative termination factor may share some aspects of their biochemical mechanisms. The general applicability of this system to the study of RNA polymerase II elongation and termination is suggested by the enhancement of termination seen at both the gastrin and human histone H3.3 gene terminators.
In eukaryotes, the 3' ends of mRNAs are generally formed by posttranscriptional processing events, such as addition of a poly(A) tail and removal of a 3' extended region from a specific RNA secondary structure. Thus the mature 3' termini do not correspond to the position of the DNA template where the RNA polymerase II (pol II) actually ceases RNA synthesis (1, 2) . pol II is known to synthesize RNA well beyond such processing sites [except in situations where it encounters premature termination sites (3, 4) ], usually terminating at sites that lie between 100 and 4000 base pairs (bp) downstream of the processing site(s) (1, 2) . Several biochemical pathways may regulate the termination process. For instance, termination in the globin gene depends on a functional poly(A) addition signal (5) , whereas the U2 RNA gene requires elements within the U2 promoter itself (6) . A terminator that is functional in any sequence context, regardless of its promoter or poly(A) signal elements, is found downstream of the poly(A) addition signal in the human gastrin gene (7, 8) . This apparent diversity in termination mechanisms in eukaryotes is reminiscent of the alternative means of termination in prokaryotes. Indeed, the biochemical complexity of termination pathways in eukaryotes may exceed that of their prokaryotic counterparts.
Based on available information, termination signals can be broadly classified into two categories: signals within or near regions with stable RNA secondary structures (9, 10) and signals that are rich in adenosine in their transcribed strand but that lack significant RNA secondary structure (7, 11) . Studies in this laboratory have focused on the gastrin gene terminator (gt), which belongs to the deoxyadenosine-rich class of terminators (7) . This terminator is highly effective in vivo (7) but weakly functional in an in vitro system that uses purified pol II (12, 13) . To understand the mechanism of termination enhancement in vivo, an in vitro system that reproduces the efficient in vivo termination would be extremely useful.
Our previous studies on the structure and function of the gt revealed that substitution of a single APT by a GC pair reduces termination activity 3-to 4-fold (K.B., R. Ito, and K.A., unpublished results). We, therefore, hypothesized that the 2-amino group ofguanine could alter the overall geometry of the distinctly narrow minor groove of the terminator, which is composed exclusively of adenine and thymine residues and that this altered form may be poorly recognized by the elongating pol II. We have tested this hypothesis by assessing the influence of a sequence-selective minor groovebinding peptide, netropsin, on pol II elongation and termination. Our data show that netropsin specifically enhances pol II termination at the gt. Termination at the deoxyadenosine-rich human histone H3.3 gene terminator (ht; ref. 11) is also significantly enhanced by netropsin in vitro, indicating that this is probably a general effect of netropsin on the deoxyadenosine-rich class of terminators.
MATERIALS AND METHODS
Construction of DNA Templates. The dC-tailed DNAs were prepared by following the general strategy described (14) . Briefly, the T1 template was constructed by adding deoxycytidine residues to the 3' ends of the Ava II-BstNI fragment that contained the gt (7, 8) . The dC-tailed Ava II fragment was produced by digestion with HindIII (12) . The T2 template was prepared similarly by 3' end tailing with deoxycytidine residues followed by isolation of the BstNI terminal dC-tailed fragment (Fig. 1) . The mutant T3 DNA, in which the thymidine residues of the termination sequence were replaced by deoxycytidine residues, was prepared by addition of deoxycytidine residues to the 3' end of the Ava II terminus (12) . The T4 and T5 templates had the ht sequence inserted in both orientations at a BstXI site upstream of the gt in the Ava II-BstNI fragment. For construction of this plasmid, the pUSTI plasmid that contained the Ava II-BstNI region was digested with BstXI, the ends were made blunt by using Klenow fragment, and the duplex between the oligonucleotides CTAGAATTTTTAAAAGAGGGACGTTTTTTTC-CCTTTTTTGGAGCTAG and CTAGCTCCAAAAAAGG-GAAAAAAACGTCCCTCTTTTAAAAATTCTAG was ligated, according to general procedures that have been described (15 (7) tailed by deoxycytidine residues was used in the construction of T1, T2, and T3 templates. Only the transcribed strand is shown. The gt sequence and its orientation with respect to direction of transcription is indicated by an arrow. Thehuman ht sequence (11) is also shown. The construction of T4 and T5 templates also used the gastrin gene Ava II-BstNI region, where the ht sequence was inserted at its BstXI site (7) . The calculated sizes of the full-length and terminated RNAs are shown for each template. th and tg represent reverse-orientation ht and gt, respectively.
Clones containing the ht oligonucleotide were isolated, and orientation of the sequence with respect to the gt was determined by nucleotide sequence analysis. The clone in which both terminators were in the same orientation was designated T4 and the other clone in which they were in opposite orientation was labeled T5 (Fig. 1) . The DNA fragments were gel purified, and their 3' ends were tailed by deoxycytidine residues as described for the T1 template (12) .
In Vitro Transcription. A typical transcription reaction contained an appropriate dC-tailed DNA template (2 nM) in 25 mM potassium Hepes, pH 7.9/0.5 mM EDTA/0.5 mM dithiothreitol/6.25 mM MgCl2/5 mM spermidine/150 mM potassium glutamate/10% (vol/vol) glycerol. This solution was incubated with the desired concentrations of netropsin (0.1-0.8 ,uM) for 30 min at 370C. Purified calf thymus pol II (1 unit) was then added, and the reaction mixture was incubated at 30'C for 30 min. The reaction was initiated by adding 500 AuM ATP, 500 j&M GTP, 500 puM UTP, 50 ,uM CTP, and 10 /LCi of CTP (3000 Ci/mmol; 1 Ci = 37 GBq) in a final volume of 12.5 ,ul followed by incubation at 370C for 10 min. The reaction was stopped by adding 1 pl of 0.5 M EDTA followed by extraction with phenol/chloroform/isoamyl alcohol. The nucleic acids were precipitated with 2 ,ug of tRNA as carrier and analyzed on 8% acrylamide/8 M urea gels. For quantitation of bands, the autoradiograms were scanned with an LKB laser densitometer.
RESULTS
Enhancement of pol II Termination by Netropsin. The efficiency of transcription termination at the gt is -95% in vivo (7) ; however, in vitro, this efficiency is only 20-25% when a dC-tailed T1 template ( Fig. 1 ) is transcribed by purified pol II (Fig. 2, lane 1) . This low termination level can be raised to in vivo levels by netropsin (lane 1 vs. 5). That the action of netropsin is terminator sequence-specific is indicated by the production of only those RNAs corresponding in length to either terminated or full-length transcripts (Fig.   2 , lanes 1-5). This result was unexpected because netropsin bound to all (A+T)-rich regions on the DNA but the RNA terminated only at the netropsin-bound terminator, as demonstrated by hydroxyl-radical footprinting of the netropsinbound DNA (data summarized in Fig. 2 ).
Netropsin could enhance termination either by modifying pol II or by specifically altering the terminator structure. The interaction of netropsin with pol II cannot be ruled out, but two lines of evidence suggest that the effect is on the DNA template: (i) overall transcription levels remain unaffected, regardless of the netropsin concentration used (Fig. 2 , compare lanes 1-5); and (ii) the level of termination depends on saturation of DNA by netropsin (0.2 nM DNA vs. 0.1 AtM netropsin) but not on pol II concentration (data not shown).
The position of pol II termination shifted several nucleotides upstream in the presence of netropsin. In the absence of netropsin, pol II transcripts terminated near the 3' termini of the consecutive runs of nine thymidines (Fig. 3, lane 1 (-95% truncated). The reason for this reduced level of termination enhancement is not known.
The 3' ends of the terminated transcripts in the presence of TFIIS were similar to their positions when TFIIS was absent, except that they were distributed along the run of nine thymidines and more RNAs terminated in the vicinity of the CC dinucleotide (Fig. 3, lane 2 (Fig. 4, lane 2 vs. 4) is in remarkably close accord with the in vivo data (7). Analysis of the mutant T3 in the presence of netropsin, in which the five thymidine residues in the transcribed strand were replaced with deoxycytidine residues (Fig. 1) , showed 25-30%o termination (Fig. 4, lane 5 vs. 6 ), very similar to the level observed in vivo (K.B., R. Ito, and K.A. unpublished results). This weak in vivo termination observed with the mutant T3 is not from reduction in the number of netropsin molecules bound to the terminator because hydroxyl-radical footprinting indicated an identical number of netropsin molecules bound to the mutant and wild-type terminators (Fig.  2) . However, the patterns of binding clearly differ. In the mutant terminator, the binding is shifted by one nucleotide in the minor groove in the proximity of the G-C base pairs (Fig.  2 ). Whether such differences could account for reduced termination activity is not known. Nevertheless, the close correlation between in vitro netropsin-enhanced and in vivo termination levels supports the possibility that the netropsin effect in the in vitro system shares some features with the in vivo termination mechanism.
For mutant T3, the position of termination shifted 3' and generated two RNAs (Fig. 4, lane 2 vs. 6 ). We have not mapped the ends of these RNAs, but in vivo studies generated similar results. This upstream shift may be from differences in the structure of netropsin-bound wild-type and mutant terminators.
Netropsin Enhances pol II Termination at the Human ht. To determine whether netropsin would enhance termination at other terminators, we examined its effect on the ht. For precise comparative assessment, both the gt and ht were placed on the same DNA, 90 nucleotides apart. This placement was accomplished by the introduction, in both orientations, of an oligonucleotide duplex containing the ht (11) into the T1 DNA at the BstXI site. The T4 construct contained the ht and the gt in the same orientation, whereas T5 construct DNA had the ht in the inverted orientation (Fig. 1) . These terminators showed similar levels of pol II termination and TFIIS-induced read-through (Fig. 5, lanes 1 and 3) . Interestingly, the activities of both terminators were enhanced to a comparable degree by netropsin (Fig. 5, lane 2 vs. 4), and the inverted orientation of the ht was also inactive (Fig. 5, lane 4) . It is noteworthy that both the gt and ht are influenced similarly by netropsin binding, even though they differ in gene origin, sequence, and relative location [the ht is located in an intron (11) conformation of the terminator may not be an important part of the pol II termination signal.
The effect of netropsin on pol II termination is not unique because other functionally related drugs, such as distamycin and bisbenzimidazole, are equally effective (data not shown), suggesting that proteins that make extensive contacts within the minor groove of 4-5 (A+T) bp could enhance termination. However, eukaryotic a-protein, which has been suggested to make contacts similar to that of netropsin with APT base pairs within the minor groove (20) , did not enhance termination (data not shown).
The most intriguing aspect of the netropsin effect on in vitro termination is that the activity of the wild-type terminator is enhanced, whereas that of the physiologically inactive mutant T2 is not. The opposite charges of netropsin and DNA and the lower dielectric constant in the minor groove are known to confer stability to the netropsin-DNA complex (21) , but these factors can contribute only to the APT basepair specificity and cannot explain the lack of activity of mutant T2.
Crystallographic analysis of netropsin bound to double helical DNA revealed that binding of netropsin widens the minor groove asymmetrically by several angstroms and bends the helical axis backward by 80 per molecule bound (22) . Therefore, one would expect the overall geometry of the minor groove in the termination sequence and the bending of the helical axis of the pol II terminator to be significantly altered because of the additive effect of each of the six bound netropsins. This number is based on the fact that 4-5 APT bp are required to bind each netropsin molecule (22) .
This highly altered asymmetric netropsin-noncanonical termination sequence complex could exhibit directionality in the pol II-catalyzed unwinding characteristics of the terminator region. Because pol II should interact and unwind the terminator area during transcription of the immediately upstream region (23) , it is conceivable that a correctly oriented drug-terminator complex does not serve as a good unwinding substrate, whereas the inversely oriented complex does. The putative transcription termination factor, whose function netropsin can mimic in vitro, could also exhibit orientationdependent binding to the terminator. The correctly oriented protein-terminator complex may resist pol II unwinding, whereas the inversely oriented complex may unwind readily.
This proposed mechanism could also explain orientationdependent action of netropsin on the ht whose sequence, A7G3A6, while different from the gt, A9T2A5TA4TA4TA5, shows some similarity in that it is also deoxyadenosine-rich. This commonality in (A+T)-rich base-pairing may be responsible for similar termination activities in the presence or absence of netropsin. Without netropsin or a putative termination factor(s), the intrinsic asymmetry might not be sufficient to effectively block transcription, but the additional asymmetry provided by the netropsin binding might enhance the effect dramatically.
In summary, the effect of netropsin on termination is specific and may be generally applicable to other terminators. Reproduction of in vivo activities of wild-type and mutant terminators suggests that netropsin and the putative termination factor(s) may share some aspects of their biochemical mechanisms.
